Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ITOS Stock Annual Income Statement. Download in Excel

iTeos Therapeutics Inc. logo

iTeos Therapeutics Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

9.07
 
USD
  
-0.09
  
(-1.04%)
Previous close: 9.165  Open: 9.04  Bid: 8.78  Ask: 9.15
52 week range    
8.20   
   18.75
Mkt Cap: 344 M  Avg Vol (90 Days): 519,295
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 11th October 2024

Stock Rankings

40
MarketXLS Rank
60
Value
30
Technical
31
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

ITOS Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
AccretionOnPreferredStock5 M
AccruedPreferredStockDividends249000.0
Basic EPS from continuing operations-2.886.12.72-3.15
Basic EPS total-2.886.12.72-3.15
Basic weighted shares outstanding15 M35 M36 M36 M
Depreciation500000.0600000.0800000.0900000.0
DepreciationAndAmortization500000.0600000.0800000.0900000.0
Diluted EPS total-2.885.682.56-3.15
Diluted normalized net income/share5.682.56-3.15
Diluted weighted shares outstanding38 M38 M36 M
GeneralAndAdministrativeExpense15 M41 M44 M50 M
Gross operating profit345 M268 M13 M
Income before tax-38 M256 M149 M-109 M
Income taxes-57000.042 M52 M4 M
Interest income78000.011 M32 M
MiscOtherSpecialCharges-48000.01 M8 M4 M
Net income from total operations-38 M215 M97 M-113 M
NetIncomeCommonStockholders-43 M215 M97 M-113 M
NetIncomeContinuousOperations-38 M215 M97 M-113 M
NetNonOperatingInterestIncomeExpense78000.011 M32 M
Normalized income-86 M
Operating income-45 M245 M126 M-151 M
Operating income before depreciation (EBITDA)-39 M256 M130 M-144 M
OperatingExpense45 M100 M141 M164 M
Other income net48000.0-1 M-8 M-4 M
OtherGandA15 M41 M44 M50 M
OtherOperatingExpenses-17 M-22 M-2 M
OtherunderPreferredStockDividend5 M
PreferredStockDividends5 M
RentAndLandingFees600000.0700000.0900000.01 M
Research & development expense30 M59 M97 M113 M
ResearchExpense30 M59 M97 M113 M
Selling Gen & administrative expense15 M41 M44 M50 M
Total Income available for interest expense (EBIT)-39 M255 M130 M-145 M
Total common shares outstanding35 M36 M36 M
Total net income-38 M215 M97 M-113 M
Total ordinary shares37 M37 M37 M37 M
Total revenues345 M268 M13 M
TotalExpenses45 M100 M141 M164 M
TotalRevenue345 M268 M13 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University